1. Home
  2. GLPG vs VC Comparison

GLPG vs VC Comparison

Compare GLPG & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GLPG
  • VC
  • Stock Information
  • Founded
  • GLPG 1999
  • VC 2000
  • Country
  • GLPG Belgium
  • VC United States
  • Employees
  • GLPG N/A
  • VC N/A
  • Industry
  • GLPG Biotechnology: Pharmaceutical Preparations
  • VC Auto Parts:O.E.M.
  • Sector
  • GLPG Health Care
  • VC Consumer Discretionary
  • Exchange
  • GLPG Nasdaq
  • VC Nasdaq
  • Market Cap
  • GLPG 1.8B
  • VC 1.9B
  • IPO Year
  • GLPG 2005
  • VC 2000
  • Fundamental
  • Price
  • GLPG $26.49
  • VC $78.04
  • Analyst Decision
  • GLPG Sell
  • VC Buy
  • Analyst Count
  • GLPG 4
  • VC 13
  • Target Price
  • GLPG $25.33
  • VC $102.50
  • AVG Volume (30 Days)
  • GLPG 389.2K
  • VC 425.2K
  • Earning Date
  • GLPG 04-23-2025
  • VC 04-24-2025
  • Dividend Yield
  • GLPG N/A
  • VC N/A
  • EPS Growth
  • GLPG N/A
  • VC N/A
  • EPS
  • GLPG N/A
  • VC 10.69
  • Revenue
  • GLPG $311,493,731.00
  • VC $3,867,000,000.00
  • Revenue This Year
  • GLPG $0.08
  • VC N/A
  • Revenue Next Year
  • GLPG $0.23
  • VC $3.80
  • P/E Ratio
  • GLPG N/A
  • VC $7.30
  • Revenue Growth
  • GLPG 18.32
  • VC N/A
  • 52 Week Low
  • GLPG $22.36
  • VC $65.10
  • 52 Week High
  • GLPG $31.23
  • VC $117.94
  • Technical
  • Relative Strength Index (RSI)
  • GLPG 65.43
  • VC 55.49
  • Support Level
  • GLPG $24.31
  • VC $69.88
  • Resistance Level
  • GLPG $24.91
  • VC $72.14
  • Average True Range (ATR)
  • GLPG 0.83
  • VC 3.89
  • MACD
  • GLPG 0.27
  • VC 1.01
  • Stochastic Oscillator
  • GLPG 95.59
  • VC 94.28

About GLPG Galapagos NV

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.

Share on Social Networks: